BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22315359)

  • 1. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
    Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
    Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
    Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.
    Hendy GN; Canaff L; Newfield RS; Tripto-Shkolnik L; Wong BY; Lee BS; Cole DE
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1311-5. PubMed ID: 24731014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
    Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
    Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
    Zajickova K; Vrbikova J; Canaff L; Pawelek PD; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2616-23. PubMed ID: 17473068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1).
    Dharmaraj P; Gorvin CM; Soni A; Nelhans ND; Olesen MK; Boon H; Cranston T; Thakker RV; Hannan FM
    J Clin Endocrinol Metab; 2020 May; 105(5):1393-400. PubMed ID: 32150253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the calcium-sensing receptor in a French family with familial hypocalciuric hypercalcaemia.
    Al-Salameh A; Cetani F; Pardi E; Vulpoi C; Pierre P; de Calan L; Guyetant S; Jeunemaitre X; Lecomte P
    Eur J Endocrinol; 2011 Aug; 165(2):359-63. PubMed ID: 21566075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
    Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
    Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
    J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.
    Szczawinska D; Schnabel D; Letz S; Schöfl C
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1146-53. PubMed ID: 24517148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial hypocalciuric hypercalcemia: a new mutation].
    Ubetagoyena Arrieta M; Castaño González L; Pérez de Nanclares Leal G; Arruebarrena Lizarraga D; Imaz Murguiondo M; Areses Trapote R
    An Pediatr (Barc); 2011 Jan; 74(1):47-50. PubMed ID: 21185797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation of the calcium-sensing receptor gene in a Greek family from Nisyros.
    Zapanti E; Polonifi A; Kokkinos M; Boutzios G; Kassi G; Nasiri Ansari N; Kassi E; Polyzos A
    Hormones (Athens); 2015; 14(2):321-5. PubMed ID: 26158657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
    Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
    BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia.
    Papadopoulou A; Gole E; Melachroinou K; Meristoudis C; Siahanidou T; Papadimitriou A
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):341-6. PubMed ID: 27087013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population.
    Nissen PH; Christensen SE; Heickendorff L; Brixen K; Mosekilde L
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4373-9. PubMed ID: 17698911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with primary hyperparathyroidism associated with familial hypocalciuric hypercalcemia induced by a novel germline CaSR gene mutation.
    Yabuta T; Miyauchi A; Inoue H; Yoshida H; Hirokawa M; Amino N
    Asian J Surg; 2009 Apr; 32(2):118-22. PubMed ID: 19423460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.